FDA approves first-in-class oral antibiotic
The drug is the first in a new class of oral antibiotics for uncomplicated urinary tract infections in nearly three decades.
List view / Grid view
The drug is the first in a new class of oral antibiotics for uncomplicated urinary tract infections in nearly three decades.
Researchers have shown how ciprofloxacin, a fluoroquinolone, affects mitochondrial DNA, and could be the cause of side effects experienced from use of the drug...